• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Global Biomarkers Market to Reach "Over $78.2 Billion by 2024"


August 03, 2016

The global biomarkers market is expected to reach over $78.2 billion by 2024, according to a new report by Grand View Research, Inc.

The reports key finding state that

•  the safety biomarkers segment held the largest share of over 40% in 2015

•  the validation biomarkers segment is determined as one of the fastest growing segments 

•  the drug discovery segment dominated the application segment in 2015

•  the cardiovascular segment is expected to be the fastest growing segment with a CAGR of over 14.0%

•  North America held the largest regional share of around 39% in 2015

•   Asia Pacific is anticipated to be the fastest growing biomarker market owing to the factors, such as the developing economic conditions, a large base of the target population, and a favorable regulatory scenario for clinical trials.


Recent Videos
Related Content